|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA08020362
|
|
(5E,7E)-8-[(3aS,4R,5R,7aR)-4-[(1Z,3E)-5-oxo-5-(isobutylamino)-penta-1,3-dienyl]-2,3,3a,4,5,7a-hexahydro-1H-inden-5-yl]octa-5,7-dienoic acid
|
NA 26:8;O
|
C26H37NO3
|
411.277344
|
|
LMFA08020363
|
|
(5E,7E)-8-[(3aS,4R,5R,7aR)-4-[(1Z,3E)-5-oxo-5-(2-methyl-butylamino)-penta-1,3-dienyl]-2,3,3a,4,5,7a-hexahydro-1H-inden-5-yl]octa-5,7-dienoic acid
|
NA 27:8;O
|
C27H39NO3
|
425.292994
|
|
LMFA08020390
|
Toporoside A
|
|
|
C43H65NO12
|
787.450680
|
|
LMFA08020391
|
Toporoside B
|
|
|
C43H65NO12
|
787.450680
|
|
LMFA04000106
|
Ectocarpin D
|
(5E,8E,11E)-12-{(1'R,2'S,3'S,5'S)-2',3'-dihydroxy-5'-[(1''R)-1''-hydroxypropyl]cyclopentyl}-5,8,11-dodecatrienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA04000105
|
Ectocarpin C
|
(5Z,8Z,11Z)-12-{(1'R,2'S,3'S,5'S)-3-[(1''E)-1''-hydroxypropyl]-6'-oxabicyclo[3.1.0]hex-2'-yl}-5,8,11-dodecatrienoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214411
|
|
LMFA04000104
|
Ectocarpin B
|
(5Z,8Z,11Z)-12-{(1'R,2'S,3'S,5'S)-3-[(1''E)-1''-propen-1''-yl]-6'-oxabicyclo[3.1.0]hex-2'-yl}-5,8,11-dodecatrienoic acid
|
FA 20:6;O
|
C20H28O3
|
316.203846
|
|
LMFA02000392
|
Ectocarpin A
|
(9Z)-10-{(1'R,2'S,3'S,5'S)-3-[(1''E)-prop-1''-en-1''-yl]-6'-oxabicyclo[3.1.0]hex-2'-yl}dec-9-enoic acid
|
FA 18:4;O
|
C18H28O3
|
292.203846
|
|
LMFA02010021
|
Dinor-iso-12-oxo-phytodienoic acid
|
6-[3-oxo-2-[(Z)-pent-2-enyl]cyclopenten-1-yl]hexanoic acid
|
FA 16:4;O
|
C16H24O3
|
264.172545
|
|
LMFA02010020
|
iso-12-oxo-PDA
|
8-[3-oxo-2-[(Z)-pent-2-enyl]cyclopenten-1-yl]octanoic acid
|
FA 18:4;O
|
C18H28O3
|
292.203846
|
|
LMFA04000107
|
C20-OPDA
|
(5Z,8Z)-10-(4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)deca-5,8-dienoic acid
|
FA 20:6;O
|
C20H28O3
|
316.203846
|
|
LMFA02010022
|
delta4-dinor-cis-OPDA
|
6-(4-oxo-5-((Z)-pent-2-en-1-yl)cyclopent-2-en-1-yl)hexa-4Z-enoic acid
|
FA 16:5;O
|
C16H22O3
|
262.156895
|
|
LMFA02010023
|
delta4-dinor-iso-OPDA
|
6-[3-oxo-2-[(Z)-pent-2-enyl]cyclopenten-1-yl]-4Z-hexenoic acid
|
FA 16:5;O
|
C16H22O3
|
262.156895
|
|
LMFA07050488
|
sapienoyl-CoA
|
6Z-hexadecenoyl-CoA
|
CoA 16:1
|
C37H64N7O17P3S
|
1003.329225
|
|
LMFA07050489
|
|
8Z-octadecenoyl-CoA
|
CoA 18:1
|
C39H68N7O17P3S
|
1031.360525
|
|
LMFA07050490
|
Sebaleoyl CoA
|
5Z,8Z-octadecadienoyl-CoA
|
CoA 18:2
|
C39H66N7O17P3S
|
1029.344875
|
|
LMFA02010024
|
Chromomoric acid
|
8-[5-hydroxy-4-oxo-5-[(Z)-pent-2-enyl]cyclopent-2-en-1-yl]octanoic acid
|
FA 18:4;O2
|
C18H28O4
|
308.198761
|
|
LMFA02010025
|
14,15-dehydro-12-oxo-phytodienoic acid
|
8-[(5E)-4-oxo-5-[(Z)-pent-2-enylidene]cyclopent-2-en-1-yl]octanoic acid
|
FA 18:5;O
|
C18H26O3
|
290.188195
|
|
LMFA02000408
|
|
8-(2-butyl-6R-hydroxy-3-oxocyclohex-1-en-yl)octanoic acid
|
FA 18:3;O2
|
C18H30O4
|
310.214411
|
|
LMFA02000409
|
|
8-(2-butyl-6S-hydroxy-3-oxocyclohex-1-en-yl)octanoic acid
|
FA 18:3;O2
|
C18H30O4
|
310.214411
|
|
LMFA02000410
|
|
7-(5S-hydroxy-2-oxo-2-pentylcyclohex-1-en-yl)heptanoic acid
|
FA 18:3;O2
|
C18H30O4
|
310.214411
|
|
LMFA02000411
|
|
7-(5R-hydroxy-2-oxo-2-pentylcyclohex-1-en-yl)heptanoic acid
|
FA 18:3;O2
|
C18H30O4
|
310.214411
|
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010075
|
PGF2alpha-EA
|
N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:3;O3
|
C22H39NO5
|
397.282824
|
|
LMFA03010152
|
PGD2-EA
|
N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA02030075
|
Callicarboric acid A
|
Methyl (1R,2R)-4-oxo-5-(2-oxo-3E-pentenyl)-2-cyclopentene-1-octanoate
|
FA 19:5;O2
|
C19H28O4
|
320.198761
|
|
LMFA02030076
|
Callicarboric acid B
|
Methyl (1S,2R)-4-oxo-5-(methyl acetoyl)-2-cyclopentene-1-octanoate
|
FA 17:4;O3
|
C17H26O5
|
310.178025
|
|
LMFA03010053
|
PGE1 alcohol
|
1,11R,15S-trihydroxy-13E-prosten-9-one
|
FA 20:2;O2
|
C20H36O4
|
340.261361
|
|
LMFA08020296
|
N-(3S,4S-methylene-decanoyl) histidine
|
N-(3S,4S-methylene-decanoyl)-histidine
|
NAHis 11:1
|
C17H27N3O3
|
321.205242
|
|
LMFA03010131
|
PGB1
|
9-oxo-15S-hydroxy-8(12),13E-prostadienoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230061
|
|
LMFA03120062
|
12-O-deacetylclavulone I
|
methyl 7S-acetoxy-9-oxo-12S-hydroxy-5Z,10Z,13Z-prostatrienoate-cyclo[8R,12]
|
FA 23:6;O4
|
C23H34O6
|
406.235541
|
|
LMFA03120063
|
clavulone I-15-one
|
methyl 4R-acetoxy-9,15-dioxo-5Z,7E,10Z,13E-prostatetraenoate-cyclo[8,12]
|
FA 25:9;O6
|
C25H32O8
|
460.209721
|
|
LMFA03010217
|
15S-hydroperoxy-PGE2
|
9-oxo-11R-hydroxy-15S-hydroperoxy-5Z,13E-prostadienoic acid
|
FA 20:4;O4
|
C20H32O6
|
368.219891
|
|
LMFA07100017
|
Lahorenoic acid B
|
Methyl 6-(2-((E)-3-oxobut-1-enyl)phenyl)hexanoate
|
SFE 17:6;O
|
C17H22O3
|
274.156895
|
|
LMFA01170162
|
|
9-[2-[4-carboxybuta-1E,3E-dienyl]phenyl]nona-2E,4Z,6E,8Z-tetraenoic acid
|
FA 20:11;O2
|
C20H18O4
|
322.120510
|
|
LMFA01170163
|
|
9-[2-[4-carboxybuta-1E,3E-dienyl]phenyl]nona-2E,4E,6E,8E-tetraenoic acid
|
FA 20:11;O2
|
C20H18O4
|
322.120510
|
|
LMFA01170164
|
|
7-[2-[4-carboxybuta-1E,3E-dienyl]phenyl]hepta-2E,4E,6E-trienoic acid
|
FA 18:10;O2
|
C18H16O4
|
296.104860
|
|
LMFA01170165
|
|
7-[2-[4-carboxybuta-1E,3E-dienyl]phenyl]hepta-2E,4E,6Z-trienoic acid
|
FA 18:10;O2
|
C18H16O4
|
296.104860
|
|
LMFA03010221
|
tetranor-PGDM
|
9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostan-1,20-dioic acid
|
FA 16:4;O5
|
C16H24O7
|
328.152205
|
|
LMFA03010089
|
2,3-dinor, 6-keto-PGF1alpha
|
6-oxo-9S,11R,15S-trihydroxy-2,3-dinor-13E-prostaenoic acid
|
FA 18:3;O4
|
C18H30O6
|
342.204241
|
|
LMFA03010243
|
Tetranor-PGAM
|
8-[(1S,5R)-5-(2-carboxyethyl)-4-oxocyclopent-2-en-1-yl]-6-oxooctanoic acid
|
FA 16:5;O4
|
C16H22O6
|
310.141640
|
|
LMFA03010244
|
PGDM
|
9alpha,11beta-dihydroxy-15-oxo-13,14-dihydro-2,3,18,19-tetranor-prostan-1,20-dioic acid
|
FA 16:4;O5
|
C16H24O7
|
328.152205
|
|
LMFA03010245
|
13,14-dihydro-15-keto-tetranor Prostaglandin D2
|
9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010246
|
13,14-dihydro-15-keto-tetranor Prostaglandin E2
|
11R-hydroxy-9,15-dioxo-2,3,4,5-tetranor-prostanoic acid
|
FA 16:3;O3
|
C16H26O5
|
298.178025
|
|
LMFA03010247
|
tetranor-PGJM
|
11,15-dioxo-2,3,4,5-tetranor-9-prosten-1,20-dioic acid
|
FA 16:5;O4
|
C16H22O6
|
310.141640
|
|
LMFA03110352
|
5-F3t-IsoP
|
(E,5S)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(2Z,5Z)-octa-2,5-dienyl]cyclopentyl]-5-hydroxyhept-6-enoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03010249
|
13,14-dihydro-15-keto-PGE2-d4
|
9,15-dioxo-11R-hydroxy-5Z-prostenoic 3,3,4,4-d4 acid
|
|
C20H28D4O5
|
356.250082
|
|
LMFA03010252
|
tetranor-PGDM-d6
|
9S-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostan-1,20-dioic-17,17,18,18,19,19-d6 acid
|
|
C16H18D6O7
|
334.189866
|
|
LMFA03110357
|
18-epi-18-F3t-IsoP
|
12S,14R,18R-trihydroxy-5Z,8Z,13E-prostatrienoic acid-cyclo[11S,15S]
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03110358
|
Tetranor-4R-4-F4t-NeuroP
|
(5Z,8Z)-10-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)deca-5,8-dienoic acid
|
FA 19:4;O3
|
C19H30O5
|
338.209326
|